PHRM.L Regulatory News (PHRM)

4 Apr 2008 16:23

Phorm Inc04 April 2008 Phorm, Inc. ("Phorm" or the "Company") Notification of Holding As a result of the issuance of placing shares in the Company's approximately £32million institutional placing announced on 19 March 2008, the Company is awarethat the following investors now have the percentage shareholdings shown below: At 3 April 2008 Number of Common Stock % of Issued Common Stock Kent Ertugrul 1,964,885 14.21% Gestrust SA 1,299,661 9.40% Dartley Holdings, Inc 629,527 4.55% Valerie Boffy No longer notifiable No longer notifiable Please note that the combined holding for Kent Ertugrul and Dartley Holdings,Inc, a Company in which Kent Ertugrul has a beneficial interest, is 18.76%. The placing shares were admitted to trading on AIM on 27 March 2008. As at 3April 2008, the Company had 13,831,224 common shares with a nominal value ofUS$0.001 per share with voting rights in issue, none of which are held intreasury. Enquiries: Kent Ertugrul (Chairman & Chief Executive) +44 20 7638 9571Lynne Millar (Chief Financial Officer) Citigate Dewe Rogerson +44 20 7638 9571Simon RigbyJustin Griffiths Canaccord Adams Limited +44 20 7050 6500(Nominated Adviser)Mark WilliamsAndrew Chubb This information is provided by RNS The company news service from the London Stock Exchange